95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.88%
Positive revenue growth while FNV is negative. John Neff might see a notable competitive edge here.
9.53%
Gross profit growth above 1.5x FNV's 1.96%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
8.65%
EBIT growth above 1.5x FNV's 1.23%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
8.65%
Operating income growth above 1.5x FNV's 1.45%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
10.43%
Net income growth of 10.43% while FNV is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
7.14%
Positive EPS growth while FNV is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
7.14%
Diluted EPS growth of 7.14% while FNV is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
0.07%
Share reduction more than 1.5x FNV's 1.74%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.09%
Diluted share reduction more than 1.5x FNV's 1.22%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
3.97%
OCF growth at 50-75% of FNV's 5.59%. Martin Whitman would question if the firm lags in monetizing sales effectively.
4.72%
Positive FCF growth while FNV is negative. John Neff would see a strong competitive edge in net cash generation.
141.61%
10Y revenue/share CAGR 1.25-1.5x FNV's 120.46%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
-20.62%
Negative 5Y CAGR while FNV stands at 26.32%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
8.81%
3Y revenue/share CAGR under 50% of FNV's 23.21%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
124.63%
10Y OCF/share CAGR at 75-90% of FNV's 141.57%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
-42.27%
Negative 5Y OCF/share CAGR while FNV is at 51.98%. Joel Greenblatt would question the firm’s operational model or cost structure.
-1.57%
Negative 3Y OCF/share CAGR while FNV stands at 106.87%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
48.42%
Below 50% of FNV's 155.02%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-61.72%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-13.79%
Negative 3Y CAGR while FNV is 0.24%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
238.97%
10Y equity/share CAGR above 1.5x FNV's 64.33%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
41.60%
5Y equity/share CAGR above 1.5x FNV's 18.67%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
16.36%
3Y equity/share CAGR at 50-75% of FNV's 22.23%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-34.46%
Negative 5Y dividend/share CAGR while FNV stands at 48.85%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-5.82%
Negative near-term dividend growth while FNV invests at 13.70%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
13.77%
Our AR growth while FNV is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
-1.47%
Negative asset growth while FNV invests at 9.60%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.03%
Under 50% of FNV's 7.67%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-10.43%
We’re deleveraging while FNV stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
15.14%
SG&A growth well above FNV's 9.43%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.